10.68EUR+0.38%Mkt Cap: 2.53B $P/E: 56.21Today
Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, a…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap2.53B $
Enterprise Value2.46B $
Revenue (TTM)1.22B $
Gross Profit947.41M $
Net Income (TTM)50.17M $
Revenue/Share5.672 USD
Last Price10.68 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2.1K
CountryES
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINES0157097017
Valuation
P/E (Trailing)56.21
P/E (Forward)19.09
PEG1.00
EV/EBITDA11.30
EV/Revenue2.02
P/S2.07
P/B1.52
EPS (TTM)0.19
EPS (Forward)0.56
52W Range
10.0616% of range13.98
52W High13.98 EUR
52W Low10.06 EUR
Profitability
Gross Margin78.66%
Oper. Margin10.26%
EBITDA Margin17.83%
Profit Margin4.17%
ROE3.10%
ROA1.97%
Growth
Revenue Growth2.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF189.63M $
CapEx (TTM)149.25M $
FCF Margin0.56%
FCF Yield0.27%
Net Debt-28.04M $
Net Debt/EBITDA-0.13
Balance Sheet
Debt/Equity0.23
Current Ratio2.31
Quick Ratio1.57
Book Value/Sh7.018 EUR
Cash/Share1.449 EUR
Dividends
Fwd Div Rate0.1900 EUR
Trail. Div Rate0.1900 EUR
Div. Yield1.75%
5Y Avg Yield1.84%
Payout Ratio98.57%
Ex-Div DateMay 14, 2026
Pay Date—
Splits
Last Split47:46
Split DateSep 14, 2020
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)14.45 EUR
Upside (mean)+35.3%
Target Range12.50 EUR – 17.50 EUR
€12.50+35.3% to mean€17.50
# Analysts12
Ownership
Shares Out.217.62M
Float77.20M
Insiders64.07%
Institutions18.03%
Technical
SMA 5011.34 (-5.8%)
SMA 20012.25 (-12.8%)
Beta0.18
S&P 52W Chg20.25%
Avg Vol (30d)70.94K
Avg Vol (10d)107.45K
Technical Indicators
RSI (14)33.3
MACD-0.1551
MACD Signal-0.0784
MACD Hist.-0.0767
BB Upper11.80 EUR
BB Middle11.22 EUR
BB Lower10.63 EUR
BB Width10.46%
ATR (14)0.2513 EUR
Vol Ratio (20d)0.91x